VitaShroom D

VitaShroom D®

  •  Our VitaShroom D® is produced in Europe with a completely controlled and traceable supply chain
  •  VitaShroom D® is standardised to provide at least 7500IUs of active vitamin D per gram, for ease of formulation
  • VitaShroom D® is completely 100% mushroom powder, with no bulking agents, fillers or excipients
  • VitaShroom D® provides a natural vegan suitable alternative to undesirable D3 which is synthesised from sheep’s wool grease
  • The vitamin D within VitaShroom D® is completed naturally occurring with no fortification
  •  Vitamin D is now the most popular vitamin in the UK market with a high amount of the population being deficient
  • 7500IU/g vitamin D
  • Excellent source of vitamin D
  • Vegan suitable vitamin D from mushrooms
  • Supports bone health

VitaShroom D® is made 100% from mushrooms that have undergone careful UV light treatment to enhance the vitamin D content. It is produced exclusively for Cambridge Commodities in Europe where the mushrooms are harvested and processed on the same site, meaning every step of the supply chain is controlled and traceable.

VitaShroom D® is an excellent source of vitamin D and helps to support teeth and bone health in children, indoor workers and the elderly. It is also a good source of other nutrients such as riboflavin, niacin and copper.

Mushrooms respond to light in a similar way to the human body by converting the sun’s rays into vitamin D. This vitamin is fat soluble and can be hard to obtain from the diet, particularly for those eating little to no animal products.

Product applications:

  • Tablets and capsules
  • Snacks
  • Drinks
  • Powder blends
  • Bakery
  • Food


  • Health & wellbeing
  • Healthy snacking
  • Food and drink
  • Sports nutrition

Contact our sales team

Vitamin d mushroom powder from Cambride Commodities

Download leaflet

Related articles

Vitamin D2 vs D3: What's the Difference?

Emma Cattell, senior research and development nutritionist addresses the difference between vitamin D2 and D3.

Read more

Subscribe to receive a copy of the CCL email newsletter